Free tool
FAERS Monitor: Loperamide Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021855 or its brand name (Loperamide Hydrochloride, Loperamide Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
21,332
Serious
11,546
54% of reports
Hospitalization
6,506
Death reported
1,898
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea3,097
- drug ineffective2,386
- nausea1,565
- fatigue1,511
- off label use1,455
- intentional product use issue977
- constipation971
- vomiting911
- incorrect dose administered877
- dyspnoea809
- headache801
- weight decreased723
- pyrexia705
- decreased appetite701
- pain663
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 319 |
| 2005 | 232 |
| 2006 | 160 |
| 2007 | 323 |
| 2008 | 372 |
| 2009 | 330 |
| 2010 | 209 |
| 2011 | 401 |
| 2012 | 355 |
| 2013 | 222 |
| 2014 | 254 |
| 2015 | 1,717 |
| 2016 | 934 |
| 2017 | 1,665 |
| 2018 | 1,395 |
| 2019 | 1,505 |
| 2020 | 1,251 |
| 2021 | 1,039 |
| 2022 | 1,514 |
| 2023 | 1,824 |
| 2024 | 1,937 |
| 2025 | 1,922 |
| 2026 | 1,452 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,827 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| intentional product use issueSignal | 977 | 11.1 | 10.4 | 8,914 |
| diarrhoeaSignal | 3,097 | 4.7 | 4.6 | 9,405 |
| constipationSignal | 971 | 4.4 | 4.1 | 2,568 |
| incorrect dose administeredSignal | 877 | 3.8 | 3.6 | 1,819 |
| decreased appetiteSignal | 701 | 3.0 | 2.8 | 929 |
| weight decreasedSignal | 723 | 2.6 | 2.4 | 692 |
| pyrexiaSignal | 705 | 2.0 | 1.9 | 363 |
| nausea | 1,565 | 2.0 | 1.9 | 752 |
| fatigue | 1,511 | 1.9 | 1.8 | 684 |
| vomiting | 911 | 1.9 | 1.8 | 404 |
| drug ineffective | 2,386 | 1.8 | 1.7 | 879 |
| off label use | 1,455 | 1.6 | 1.6 | 377 |
| dyspnoea | 809 | 1.4 | 1.3 | 98 |
| headache | 801 | 1.3 | 1.2 | 44 |
| pain | 663 | 1.1 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.